These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23067318)

  • 21. Use of an exposure-response model to aid early drug development of an oral sphingosine 1-phosphate receptor modulator.
    Rohatagi S; Zahir H; Moberly JB; Truitt KE; Inaba S; Shimozato T; Carrothers TJ
    J Clin Pharmacol; 2009 Jan; 49(1):50-62. PubMed ID: 18948412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 2. Synthesis and characterization of a novel imide-type prodrug for improving oral absorption.
    Okaniwa M; Imada T; Ohashi T; Miyazaki T; Arita T; Yabuki M; Sumita A; Tsutsumi S; Higashikawa K; Takagi T; Kawamoto T; Inui Y; Yoshida S; Ishikawa T
    Bioorg Med Chem; 2012 Aug; 20(15):4680-92. PubMed ID: 22763369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationship studies of S1P agonists with a dihydronaphthalene scaffold.
    Kurata H; Kusumi K; Otsuki K; Suzuki R; Kurono M; Tokuda N; Takada Y; Shioya H; Mizuno H; Komiya T; Ono T; Hagiya H; Minami M; Nakade S; Habashita H
    Bioorg Med Chem Lett; 2012 Jan; 22(1):144-8. PubMed ID: 22153936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists.
    Horan JC; Sanyal S; Choi Y; Hill-Drzewi M; Patnaude L; Anderson S; Fogal S; Mao C; Cook BN; Gueneva-Boucheva K; Fisher MB; Hickey E; Pack E; Bannen LC; Chan DS; Mac MB; Ng SM; Wang Y; Xu W; Modis LK; Lemieux RM
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4807-11. PubMed ID: 25241927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo.
    Roviezzo F; Brancaleone V; De Gruttola L; Vellecco V; Bucci M; D'Agostino B; Cooper D; Sorrentino R; Perretti M; Cirino G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):830-7. PubMed ID: 21421740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of thiadiazole amides as potent, S1P₃-sparing agonists of sphingosine-1-phosphate 1 (S1P₁) receptor.
    Xu H; Zhang H; Luan L; Xu Y; Li C; Wang Y; Han F; Yang T; Ren F; Xiang JN; Elliott JD; Zhao Y; Guo TB; Lu H; Zhang W; Hirst D; Lindon M; Lin X
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2456-9. PubMed ID: 22386243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Optimization of Benzimidazole Sulfonamides as Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists with in Vivo Activity.
    Hennessy EJ; Oza V; Adam A; Byth K; Castriotta L; Grewal G; Hamilton GA; Kamhi VM; Lewis P; Li D; Lyne P; Öster L; Rooney MT; Saeh JC; Sha L; Su Q; Wen S; Xue Y; Yang B
    J Med Chem; 2015 Sep; 58(17):7057-75. PubMed ID: 26291341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Removal of sphingosine 1-phosphate receptor-3 (S1P(3)) agonism is essential, but inadequate to obtain immunomodulating 2-aminopropane-1,3-diol S1P(1) agonists with reduced effect on heart rate.
    Hamada M; Nakamura M; Kiuchi M; Marukawa K; Tomatsu A; Shimano K; Sato N; Sugahara K; Asayama M; Takagi K; Adachi K
    J Med Chem; 2010 Apr; 53(8):3154-68. PubMed ID: 20337461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator.
    Ter Braak M; Claas RF; Hegen B; Labocha S; Ferreirós N; Pfeilschifter J; Huwiler A; van Echten-Deckert G; Meyer Zu Heringdorf D
    Biochem Pharmacol; 2011 Mar; 81(5):617-25. PubMed ID: 21163254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reduction of allograft arteriosclerosis in intestinal transplant is associated with sphingosine kinase 1/sphingosine-1-phosphate signaling after fish oil treatment.
    Li Q; Wang C; Zhang Q; Tang C; Li N; Li J
    Transplantation; 2012 May; 93(10):989-96. PubMed ID: 22466786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingosine 1-phosphate accelerates wound healing in diabetic mice.
    Kawanabe T; Kawakami T; Yatomi Y; Shimada S; Soma Y
    J Dermatol Sci; 2007 Oct; 48(1):53-60. PubMed ID: 17643267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic/pharmacodynamic modelling of 2-acetyl-4(5)-tetrahydroxybutyl imidazole-induced peripheral lymphocyte sequestration through increasing lymphoid sphingosine 1-phosphate.
    Yu XQ; Kramer J; Moran L; O'Neill E; Nouraldeen A; Oravecz T; Wilson AG
    Xenobiotica; 2010 May; 40(5):350-6. PubMed ID: 20175664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists.
    Bolli MH; Abele S; Binkert C; Bravo R; Buchmann S; Bur D; Gatfield J; Hess P; Kohl C; Mangold C; Mathys B; Menyhart K; Müller C; Nayler O; Scherz M; Schmidt G; Sippel V; Steiner B; Strasser D; Treiber A; Weller T
    J Med Chem; 2010 May; 53(10):4198-211. PubMed ID: 20446681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonists.
    Aguilar N; Mir M; Grima PM; López M; Segarra V; Esteban L; Moreno I; Godessart N; Tarrasón G; Domenech T; Vilella D; Armengol C; Córdoba M; Sabaté M; Casals D; Domínguez M
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7672-6. PubMed ID: 23141913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor.
    Liu C; Lin J; Hynes J; Wu H; Wrobleski ST; Lin S; Dhar TG; Vrudhula VM; Sun JH; Chao S; Zhao R; Wang B; Chen BC; Everlof G; Gesenberg C; Zhang H; Marathe PH; McIntyre KW; Taylor TL; Gillooly K; Shuster DJ; McKinnon M; Dodd JH; Barrish JC; Schieven GL; Leftheris K
    J Med Chem; 2015 Oct; 58(19):7775-84. PubMed ID: 26359680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploration of potential prodrugs of RWJ-445167, an oxyguanidine-based dual inhibitor of thrombin and factor Xa.
    Maryanoff BE; McComsey DF; Costanzo MJ; Yabut SC; Lu T; Player MR; Giardino EC; Damiano BP
    Chem Biol Drug Des; 2006 Jul; 68(1):29-36. PubMed ID: 16923023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
    Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD
    J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological and pharmacokinetic evaluation of celecoxib prodrugs in rats.
    Mamidi RN; Mullangi R; Kota J; Bhamidipati R; Khan AA; Katneni K; Datla S; Singh SK; Rao KY; Rao CS; Srinivas NR; Rajagopalan R
    Biopharm Drug Dispos; 2002 Oct; 23(7):273-82. PubMed ID: 12355578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors.
    Dang Q; Kasibhatla SR; Jiang T; Fan K; Liu Y; Taplin F; Schulz W; Cashion DK; Reddy KR; van Poelje PD; Fujitaki JM; Potter SC; Erion MD
    J Med Chem; 2008 Jul; 51(14):4331-9. PubMed ID: 18570362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.